-
What Investors Should Expect From Rockwell Medical's Next FDA Decision
Wednesday, January 7, 2015 - 5:22pm | 359Read More...On Wednesday, Rockwell Medical Inc (NASDAQ: RMTI) announced it will be presenting two Triferic abstracts at the Annual Dialysis Conference on February 2 in New Orleans. Triferic is the company's iron-replacement drug used for iron deficiency in chronic kidney disease patients receiving...
